Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Metoclopramide for Upper GI Bleeding (MANPURSE)
NCT03840057Phase 2Unknown
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of azithromycin in upper gastrointestinal bleeding (UGIB) (3 arms). Primary endpoints: Rate of Reduction in the Need for Second Endoscopy at 48 hours, Adverse Cardiac Side Effects related to Intervention at 5 days and 2 more. Status: unknown.
02
Drugs
azithromycin
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT03840057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840057.